QUIZ: According to the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease, which of the following therapies should be considered first for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) in patients with elevated low-density lipoprotein cholesterol levels (190 mg/dL or higher), those with diabetes mellitus who are age 40 to 75 years, and those determined to be at sufficient ASCVD risk after a clinician–patient risk discussion? (Statins; SGLT2; GLP1)
According to the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease, which of the following therapies should be considered first for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) in patients with elevated low-density lipoprotein cholesterol levels (190 mg/dL or higher), those with diabetes mellitus who are age 40 to 75 years, and those determined to be at sufficient ASCVD risk after a clinician–patient risk discussion?
Better luck next time
For more cardiovascular disease content, visit the Specialty Site.
Nice job!